181 related articles for article (PubMed ID: 24682137)
21. Treatment of digital ulcers in systemic sclerosis: Case series study of thirteen patients and discussion on outcome.
Abuowda Y; Almeida RS; Oliveira AA; Pego P; Santos C; Matos-Costa J
Rev Assoc Med Bras (1992); 2017 May; 63(5):422-426. PubMed ID: 28724039
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Vascular Complications in Systemic Sclerosis: What Is the Best Approach to Diagnosis and Management of Renal Crisis and Digital Ulcers?
Hughes M; Herrick AL; Hudson M
Rheum Dis Clin North Am; 2023 May; 49(2):263-277. PubMed ID: 37028834
[TBL] [Abstract][Full Text] [Related]
23. [Digital ulcers in systemic sclerosis : A retrospective heath service study analysing treatment with bosentan and other vasoactive therapies].
Riemekasten G; Beissert S; Distler JH; Kreuter A; Müller-Ladner U
Z Rheumatol; 2017 Apr; 76(3):228-237. PubMed ID: 27535277
[TBL] [Abstract][Full Text] [Related]
24. Bosentan as a rescue therapy in scleroderma refractory digital ulcers.
Chamaillard M; Heliot-Hosten I; Constans J; Taïeb A
Arch Dermatol; 2007 Jan; 143(1):125-6. PubMed ID: 17224564
[No Abstract] [Full Text] [Related]
25. Successful treatment of systemic sclerosis-related digital ulcers and sarcoidosis with endothelin receptor antagonist (bosentan) therapy.
Tillon J; Hervé F; Chevallier D; Muir JF; Levesque H; Marie I
Br J Dermatol; 2006 May; 154(5):1000-2. PubMed ID: 16634913
[No Abstract] [Full Text] [Related]
26. Endothelin receptor antagonists and scleroderma related digital ulcers.
Lee WY; Faruqi S; Morice AH
Acta Reumatol Port; 2013; 38(1):58-9. PubMed ID: 24131915
[No Abstract] [Full Text] [Related]
27. Management of Raynaud's phenomenon and digital ulcers in systemic sclerosis.
Botzoris V; Drosos AA
Joint Bone Spine; 2011 Jul; 78(4):341-6. PubMed ID: 21183379
[TBL] [Abstract][Full Text] [Related]
28. Effect of a sequential therapy of bosentan and iloprost versus a monotherapy with bosentan in the treatment of scleroderma related digital ulcers.
Hafner F; Thomas G; Froehlich H; Steidl K; Brodmann M
Int Angiol; 2011 Oct; 30(5):493-5. PubMed ID: 21804491
[No Abstract] [Full Text] [Related]
29. Treatment of digital ulcers in systemic sclerosis: recent developments and future perspectives.
Sagonas I; Daoussis D
Clin Rheumatol; 2023 Oct; 42(10):2589-2599. PubMed ID: 36847929
[TBL] [Abstract][Full Text] [Related]
30. Digital ulcers in scleroderma patients: A retrospective observational study.
De Cata A; Inglese M; Molinaro F; De Cosmo S; Rubino R; Bernal M; Mazzoccoli G
Int J Immunopathol Pharmacol; 2016 Jun; 29(2):180-7. PubMed ID: 26684622
[TBL] [Abstract][Full Text] [Related]
31. Bosentan in systemic sclerosis.
Heresi GA; Minai OA
Drugs Today (Barc); 2008 Jun; 44(6):415-28. PubMed ID: 18596996
[TBL] [Abstract][Full Text] [Related]
32. Blood flow in the hands of a predefined homogeneous systemic sclerosis population: the presence of digital ulcers and the improvement with bosentan.
Meijs J; Voskuyl AE; Bloemsaat-Minekus JP; Vonk MC
Rheumatology (Oxford); 2015 Feb; 54(2):262-9. PubMed ID: 25150178
[TBL] [Abstract][Full Text] [Related]
33. Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangrene.
Ichimura Y; Asano Y; Hatano M; Tamaki Z; Takekoshi T; Kogure A; Tomita M; Kawashima T; Miyazaki M; Taniguchi T; Takahashi T; Mitsui H; Sugaya M; Yao A; Kinugawa K; Sato S
Mod Rheumatol; 2011 Oct; 21(5):548-52. PubMed ID: 21547701
[TBL] [Abstract][Full Text] [Related]
34. Effects of Bosentan in the Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: A Longitudinal, Multicenter, Uncontrolled Trial.
Lee KA; Park S; Kim BY; Kim YS; Ju JH; Son CN; Kim SH; Kim HS
J Clin Rheumatol; 2021 Dec; 27(8):e599-e601. PubMed ID: 33448749
[No Abstract] [Full Text] [Related]
35. Bosentan for digital ulcers in patients with systemic sclerosis: a prospective 3-year followup study.
Tsifetaki N; Botzoris V; Alamanos Y; Argyriou E; Zioga A; Drosos AA
J Rheumatol; 2009 Jul; 36(7):1550-2. PubMed ID: 19567637
[No Abstract] [Full Text] [Related]
36. Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials.
Khanna D; Denton CP; Merkel PA; Krieg T; Le Brun FO; Marr A; Papadakis K; Pope J; Matucci-Cerinic M; Furst DE; ;
JAMA; 2016 May; 315(18):1975-88. PubMed ID: 27163986
[TBL] [Abstract][Full Text] [Related]
37. Digital ulcers in systemic sclerosis.
Hughes M; Herrick AL
Rheumatology (Oxford); 2017 Jan; 56(1):14-25. PubMed ID: 27094599
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy of bosentan in the treatment of digital ulcers secondary to thromboangiitis obliterans].
Prior Á; Rodriguez-Muguruza S; Sanint J; Olivé A
Med Clin (Barc); 2015 Jul; 145(1):44. PubMed ID: 25433787
[No Abstract] [Full Text] [Related]
39. Digital ulcers and outcomes assessment in scleroderma.
Matucci-Cerinic M; Seibold JR
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v46-7. PubMed ID: 18784143
[TBL] [Abstract][Full Text] [Related]
40. [Digital ulcers in systemic sclerosis--an interdisciplinary challenge].
Wiesent F; Weinerth J
Med Klin (Munich); 2010 Aug; 105(8):578-81. PubMed ID: 20824416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
